Prosecution Insights
Last updated: August 17, 2026
Application No. 18/874,374

ALKANOLAMINE FORMATES FOR ENZYME STABILIZATION IN LIQUID FORMULATIONS

Non-Final OA §103
Filed
Dec 12, 2024
Priority
Jul 15, 2022 — EU 22185185.0 +1 more
Examiner
BOYER, CHARLES I
Art Unit
1764
Tech Center
1700 — Chemical & Materials Engineering
Assignee
BASF SE
OA Round
1 (Non-Final)
70%
Grant Probability
Favorable
1-2
OA Rounds
7m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allowance Rate
779 granted / 1108 resolved
+5.3% vs TC avg
Strong +20% interview lift
Without
With
+19.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 3m
Avg Prosecution
34 currently pending
Career history
1143
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
49.6%
+9.6% vs TC avg
§102
27.1%
-12.9% vs TC avg
§112
14.1%
-25.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1108 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-9, 13, 16, 17, and 19 are rejected under 35 U.S.C. 103 as being unpatentable over Kaneko et al, US 2024/0057587. Kaneko et al teach a solid enzyme stabilizer composition, wherein a preferred stabilizer is triethanolamine formate (¶283). These compounds are formed as a 50% solution where an enzyme is added and dissolved therein at a stabilizer:enzyme ratio of 10:1 (¶754 and table 11). Though ultimately the water is removed, before this occurs, a stabilizer and enzyme are present as a liquid, and so claim 1 is satisfied when triethanolamine formate is used as the stabilizer, which is obvious to use as it is taught as a preferred stabilizer by the reference. Claims 1, 2, and 4-20 are rejected under 35 U.S.C. 103 as being unpatentable over Letton et al, US 4,318,818. Letton et al teach a liquid detergent composition with a stabilized aqueous enzyme composition comprising LAS, 1% triethanolamine formate, propylene glycol, 0.05% protease, and the balance water (col. 10, lines 39-45 and example III). The enzyme may be present in amounts as high as 10% and the formate salt may be present in amounts as high as 10% (claim 15). It would have been obvious for one of ordinary skill in the art to use greater amounts of enzyme and triethanolamine formate in example III as greater amounts are contemplated by the reference. With respect to the method of making the composition, as the title of the invention is stabilized aqueous enzyme compositions, the examiner maintains this limitation is satisfied, and in any event, it is not inventive to add water to a detergent ingredient. Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHARLES I BOYER whose telephone number is (571)272-1311. The examiner can normally be reached M-S 10-430. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew can be reached at 5712722817. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CHARLES I BOYER/Primary Examiner, Art Unit 1761
Read full office action

Prosecution Timeline

Dec 12, 2024
Application Filed
Jul 29, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12703839
FLOOR STRIPPING COMPOSITIONS FREE OF FLUORINATED SURFACTANTS AND METHODS OF USING THE SAME
3y 3m to grant Granted Aug 11, 2026
Patent 12692458
PARTICULATE LAUNDRY SOFTENING AND FRESHENING WASH ADDITIVE
2y 11m to grant Granted Jul 28, 2026
Patent 12680053
A METHOD FOR MANUFACTURING A RESIST PATTERN USING AN AQUEOUS CLEANING SOLUTION COMPRISING A C4-C12 ALKYLCARBOXYLIC ACID
3y 9m to grant Granted Jul 14, 2026
Patent 12672657
COMPOSITIONS, METHODS AND SYSTEMS FOR ELECTROLYTIC TREATMENT OF MYCOTOXIN, GLYPHOSATE, AND MICROBIAL CONTAMINATION
3y 11m to grant Granted Jul 07, 2026
Patent 12673016
COACERVATE CLEANSING COMPOSITION
2y 7m to grant Granted Jul 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
70%
Grant Probability
90%
With Interview (+19.5%)
2y 3m (~7m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1108 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month